The lawsuit revolved around Insulet's Omnipod tubeless insulin pump – used with continuous glucose monitors (CGMs) to create an artificial pancreas system used by diabetics – and claimed that ...

The Massachusetts-based company's 'hybrid closed-loop insulin pump', the Omnipod Horizon ... the Omnipod is the world's first commercially available tubeless insulin delivery system, delivering ...

Insulet Corporation (NASDAQ: PODD) (“Insulet” or the “Company”), the global leader in tubeless insulin pump technology with its Omnipod® brand of products, today announced its intention ...

The Global Insulin Pump Market achieved a valuation of $5.90 Billion in 2024 and is anticipated to exceed $14.49 Billion by 2035, reflecting a compounded annual growth rate (CAGR) of 8.55% during the ...

Insulet Corporation (NASDAQ: PODD) (“Insulet” or the “Company”), the global leader in tubeless insulin pump technology with its Omnipod® brand of products, has priced a private placement ...

Insulet Corporation, a global leader in tubeless insulin pump technology with its Omnipod brand of products, shared new Omnipod 5 clinical data from its RADIANT study. Results from this multinational ...

ACTON, Mass.--(BUSINESS WIRE)--Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod ® brand of products, today announced ...

“We want to position and develop the Malaysian operation as a regional hub for the manufacturing of our tubeless insulin pump under the Omnipod brandname,” Hollingshead told StarBiz ...